NO971449L - Nye hormonelle medikamenter og anvendelse derav for korrigering av östrogenmangel - Google Patents

Nye hormonelle medikamenter og anvendelse derav for korrigering av östrogenmangel

Info

Publication number
NO971449L
NO971449L NO971449A NO971449A NO971449L NO 971449 L NO971449 L NO 971449L NO 971449 A NO971449 A NO 971449A NO 971449 A NO971449 A NO 971449A NO 971449 L NO971449 L NO 971449L
Authority
NO
Norway
Prior art keywords
correction
estrogen deficiency
hormonal medications
new hormonal
new
Prior art date
Application number
NO971449A
Other languages
English (en)
Other versions
NO312996B1 (no
NO971449D0 (no
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Original Assignee
Lab Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO971449(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lab Theramex filed Critical Lab Theramex
Publication of NO971449D0 publication Critical patent/NO971449D0/no
Publication of NO971449L publication Critical patent/NO971449L/no
Publication of NO312996B1 publication Critical patent/NO312996B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19971449A 1995-08-01 1997-03-26 Hormonell, östroprogestativ trisekvensiell kombinasjon og fremgangsmåte for fremstilling av en slik NO312996B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509364A FR2737411B1 (fr) 1995-08-01 1995-08-01 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
PCT/IB1996/000754 WO1997004784A1 (fr) 1995-08-01 1996-07-29 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques

Publications (3)

Publication Number Publication Date
NO971449D0 NO971449D0 (no) 1997-03-26
NO971449L true NO971449L (no) 1997-05-30
NO312996B1 NO312996B1 (no) 2002-07-29

Family

ID=9481610

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971449A NO312996B1 (no) 1995-08-01 1997-03-26 Hormonell, östroprogestativ trisekvensiell kombinasjon og fremgangsmåte for fremstilling av en slik

Country Status (30)

Country Link
US (1) US5891867A (no)
EP (1) EP0783310B1 (no)
JP (1) JPH10507207A (no)
KR (1) KR100450649B1 (no)
CN (1) CN1138547C (no)
AP (1) AP829A (no)
AR (1) AR004502A1 (no)
AT (1) ATE225659T1 (no)
AU (1) AU722355B2 (no)
BR (1) BR9606549A (no)
CA (1) CA2201368C (no)
CZ (1) CZ289706B6 (no)
DE (1) DE69624214T2 (no)
DK (1) DK0783310T3 (no)
DZ (1) DZ2078A1 (no)
ES (1) ES2184880T3 (no)
FR (1) FR2737411B1 (no)
HU (1) HU229843B1 (no)
IL (1) IL120558A (no)
MA (1) MA23946A1 (no)
MX (1) MX9702381A (no)
MY (1) MY117307A (no)
NO (1) NO312996B1 (no)
OA (1) OA10411A (no)
PT (1) PT783310E (no)
RU (1) RU2188641C2 (no)
TN (1) TNSN96101A1 (no)
TW (1) TW473390B (no)
WO (1) WO1997004784A1 (no)
ZA (1) ZA966545B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
EP1390038A2 (en) 2001-05-16 2004-02-25 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
NZ591627A (en) * 2001-12-05 2012-09-28 Teva Womens Health Inc Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
AR065816A1 (es) * 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4870066A (en) * 1986-08-11 1989-09-26 The University Of Kentucky Research Foundation Method and composition for safely delaying parturition and synchronizing farrowing in swine
EP0483077B1 (en) * 1990-09-28 1995-12-06 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Also Published As

Publication number Publication date
PT783310E (pt) 2003-02-28
ATE225659T1 (de) 2002-10-15
NO312996B1 (no) 2002-07-29
CZ96797A3 (cs) 1998-08-12
ZA966545B (en) 1997-05-08
NO971449D0 (no) 1997-03-26
MY117307A (en) 2004-06-30
AU722355B2 (en) 2000-07-27
HUP9900612A3 (en) 1999-11-29
DE69624214D1 (de) 2002-11-14
TNSN96101A1 (fr) 2005-03-15
ES2184880T3 (es) 2003-04-16
IL120558A0 (en) 1997-07-13
IL120558A (en) 2002-09-12
CZ289706B6 (cs) 2002-03-13
EP0783310A1 (fr) 1997-07-16
OA10411A (fr) 2001-12-06
AP829A (en) 2000-05-03
FR2737411B1 (fr) 1997-10-17
DE69624214T2 (de) 2003-07-10
HUP9900612A2 (hu) 1999-07-28
AR004502A1 (es) 1998-12-16
AU6367496A (en) 1997-02-26
KR970706004A (ko) 1997-11-03
HU229843B1 (en) 2014-09-29
DK0783310T3 (da) 2003-02-10
CA2201368C (fr) 2010-12-07
DZ2078A1 (fr) 2002-10-22
WO1997004784A1 (fr) 1997-02-13
MX9702381A (es) 1998-02-28
CN1167438A (zh) 1997-12-10
MA23946A1 (fr) 1997-04-01
JPH10507207A (ja) 1998-07-14
CA2201368A1 (fr) 1997-02-13
BR9606549A (pt) 1998-06-23
HK1005227A1 (en) 1998-12-31
RU2188641C2 (ru) 2002-09-10
TW473390B (en) 2002-01-21
FR2737411A1 (fr) 1997-02-07
AP9700979A0 (en) 1997-07-31
KR100450649B1 (ko) 2004-11-16
US5891867A (en) 1999-04-06
EP0783310B1 (fr) 2002-10-09
CN1138547C (zh) 2004-02-18

Similar Documents

Publication Publication Date Title
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
NO962179D0 (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
IS4557A (is) Notkun fumagillóls og afleiða þess við framleiðslu lyfja gegn þarmasýkingu
DE69513671D1 (de) Arzneimittel
DE69633368D1 (de) Zementbindeverzögerer und zementabbindeverzögerer-folie
NO308740B1 (no) Kinazolinderivater, anvendelse derav og farmasøytisk blanding
DK0850426T3 (da) Transpondearrangement
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
DE69434376D1 (de) Videotrainingsverfahren und display
DE69712839D1 (de) Tcas computer und anzeige
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO984094L (no) Utladningsreaktor og anvendelse av samme
DE69737936D1 (de) Arzneimittel
DE69524889D1 (de) Mechanisch verbundenes target und adapter dafür
NO964102D0 (no) Farmasöytiske preparater og medikamenter for forebyggelse og behandling av endotheliale dysfunksjoner
NO971449D0 (no) Nye hormonelle medikamenter og anvendelse derav for korrigering av östrogen-mangel
DE69628248D1 (de) Graphenanzeigevorrichtungen und -verfahren
DE69615544D1 (de) Anzeigeverfahren und anzeigevorrichtung
AU3815495A (en) Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
AU4546496A (en) Orthopaedic casting and splinting materials
DE59610423D1 (de) Partikulare arzneiform
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
KR970001311A (ko) 에틸 아미도 플루오렌 유도체 및 이를 함유한 약제조성물
EP0776666A3 (en) Analgesic and anti-inflammatory medication

Legal Events

Date Code Title Description
MK1K Patent expired